Article

Clinical Trial: New Imaging Techniques in the Evaluation of Patients With Ectopic Cushing Syndrome

This trial will determine if a new imaging technique will be able to localize the source of ectopic ACTH production.

New Imaging Techniques in the Evaluation of Patients With Ectopic Cushing Syndrome

Study Type: Observational

Age/Gender Requirements: 18-70 years (male/female)

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development

Purpose: To determine “whether [18-F]-fluorodeoxyglucose (FDG) or use of a higher dose of [111In-DTPA-D-Phe]-pentetreotide can be used to successfully localize the source of ectopic ACTH production.”

Click here to access this third-party resource.

Related Videos
Diabetes Dialogue: Diabetes Tech Updates from November 2024 | Image Credit: HCPLive
Diabetes Dialogue: Tirzepatide’s Long-Term Obesity Data | Image Credit: HCPLive
Diabetes Dialogue: Latest Updates on Semaglutide Shortage, Data | Image Credit: HCPLive
Richard Pratley, MD | Credit: Advent Health Diabetes Institute
Rahul Aggarwal, MD | Credit: LinkedIn
Brendon Neuen, MBBS, PhD | Credit: X.com
HCPLive Five at ADA 2024 | Image Credit: HCPLive
Ralph DeFronzo, MD | Credit: UT San Antonio
Timothy Garvey, MD | Credit: University of Alabama at Birmingham
Atul Malhotra, MD | Credit: Kyle Dykes; UC San Diego Health
© 2024 MJH Life Sciences

All rights reserved.